ADGM — Adagio Medical Holdings Share News
0.000.00%
Last trade - 00:00Brief: Adagio Medical Announces Strategic Review Process To Maximize Shareholder Value
Adagio Medical Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Adagio Medical Holdings Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Adagio Medical Reports Second Quarter 2026 Results
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM
NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
Brief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron
Adagio Medical rises after FDA clears expanded testing of heart device
Brief: Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
Brief: Adagio Medical Completes Enrollment For Pivotal VT Cryoablation Trial
Brief: Adagio Medical Elevates Deborah Kaster to Dual Role as CBO and CFO
Brief: Adagio Medical Reports First Quarter 2025 Results